Medplus Share Price (MEDPLUS)
as on
| Source : NSE
Medplus Stock Performance
as on August 14, 2025 at 4:01 PM IST
Day's Low
Day's High
₹805.35₹829.6
1.04%
Downside
1.94%
Upside
52 Week's Low
52 Week's High
₹616₹1,045.324.31%
Downside
28.45%
Upside
| Market Stats | |
| Previous Close | ₹804.05 |
| Open | ₹806.90 |
| Volume | 2.04L |
| Upper Circuit | ₹964.85 |
| Lower Circuit | ₹643.25 |
| Day's Low | ₹805.35 |
| Day's High | ₹829.6 |
| 52 Week Low | ₹616 |
| 52 Week High | ₹1,045.3 |
| Returns % | |
| 1 Month Return | -12.22 % |
| 3 Month Return | -8.1 % |
| 1 Year Return | + 26.72 % |
| 3 Year Return | + 6.62 % |
| 5 Year Return | -27.41 % |
Medplus Stock Fundamentals & Key Indicators
Check Medplus market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹9,744.72 Cr
Return on Equity (ROE)
0.75
PE Ratio (TTM)
54.47
Return on capital employed (ROCE)
1.13
Industry PE ratio
0Beta (LTM)
0.76
P/B Ratio
7.03
Dividend Yield
0PEG Ratio
6.36
Quarterly Earnings Growth YOY
195.26
EPS (TTM)
5.49
Sector
Retail
Book Value
132.01
Technical Analysis
Bearish
View Technical Analysis
Medplus Stock's Interest Amongst Investors
Medplus Stock Valuation
Track how Medplus P/E has moved over time to understand its valuation trends.
Medplus in the last 5 years
Lowest (53.82x)
August 13, 2025
Industry (0.00x)
August 14, 2025
Today (54.47x)
August 14, 2025
Highest (263.63x)
March 17, 2023
Today’s Price to Earnings Ratio: 54.47x
Medplus Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Medplus.
based on 7 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Medplus. Average target price of ₹1059.71
Source: S&P Global Market Intelligence
Medplus Share Price Target
Get share price movements and forecasts by analysts on Medplus.
Medplus price forecast by 7 analysts
Upside of30.22%
High
₹1180
Target
₹1059.71
Low
₹933
Medplus target price ₹1059.71, a slight upside of 30.22% compared to current price of ₹813.8. According to 7 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medplus revenue growth forecast
Expected growth rate Q1, FY2027:33.18%
Forecast
Actual
Including amortisation and stock based compensations
Medplus EPS growth forecast
EPS estimate Q1, FY2027:293.43%
Forecast
Actual
Source: S&P Global Market Intelligence
Medplus Health Services Ltd Financial Results
Get the annual and quarterly financial summary of Medplus Health Services Ltd, including revenue, profit, loss and more.
Medplus Earnings and Dividends
View detailed summary of the earnings and dividend history of Medplus.
Medplus Health Services Ltd Earnings Results
Medplus Health Services Ltd’s net profit jumped 194.99% since last year same period to ₹42.36Cr in the Q1 2025-2026. On a quarterly growth basis, Medplus Health Services Ltd has generated -17.49% fall in its net profits since last 3-months.
Read More about Earnings Results
Indices Featuring Medplus Stock
Check stock indices that include Medplus.
Medplus Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Medplus.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 40.32% | ||
| Foreign Institutions | 16.42% | 5.23 | |
| Mutual Funds | 21.47% | ||
| Retail Investors | 17.18% | ||
| Others | 4.61% |
Medplus Health Services Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Medplus with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 9,744.72 | -5.48% | 0.70 | 65 | 5,624 | |
| NA | 98.36 | 34.48% | 0.51 | -1 | 8 | |
| NA | 2,642.21 | 42.34% | 0.55 | 77 | 5,696 | |
| HOLD | 9,152.00 | -8.73% | 0.87 | -736 | 13,995 | |
| NA | 1,877.05 | 287.23% | 0.69 | 11 | 131 |
Medplus News & Key Events
Latest news and events in one place to help you make informed investing decisions in Medplus.
Medplus Health Reports Strong Q1 Growth Amid Stock Dip - 04 Aug, 2025
Medplus Health Services reported a remarkable 194.99% increase in net profit for Q1 FY26, alongside a 41% rise in EBITDA. The company plans to expand its store count by 600 by FY26-end, although shares dipped slightly by 0.07%. Overall, the financial performance indicates strong growth despite the stock's minor decline.Medplus Set to Release Q1 Earnings Today - 02 Aug, 2025
Medplus Health Services is scheduled to announce its Q1 earnings report today, August 2, along with 55 other companies.
Insights on Medplus Health Services Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 1.52K Cr → 1.55K Cr (in ₹), with an average increase of 2.1% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 15.61% to 16.42% in Jun 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, MEDPLUS stock has moved up by 26.7%
NO EFFECTAgainst Peers
In the last 1 year, Novelix Pharmaceuticals Ltd has given 90.3% return, outperforming this stock by 63.6%
- NO EFFECT
Against Peers
In the last 3 years, Novelix Pharmaceuticals Ltd has given 422.5% return, outperforming this stock by 415.9%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 21.59% to 21.47% in Jun 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 51.34 Cr → 42.36 Cr (in ₹), with an average decrease of 17.5% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 40.34% to 40.32% in Jun 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 17.82% to 17.18% in Jun 2025 quarter
About Medplus Health Services Ltd
The company's retail pharmacy offers an extensive selection of prescription and over-the-counter medicines, including popular brands such as Pfizer, Novartis, and GlaxoSmithKline. It also stocks a wide range of health and wellness products, including vitamins, supplements, and herbal products.
Medplus also offers a variety of healthcare services, including home nursing, physiotherapy, and medical equipment rental. Its diagnostic services include X-ray, ultrasound, and lab tests. The company also provides health check-up packages and health insurance services.
Revenue: ₹1,542.63Cr as on June 2025 (Q1 FY26)
Net Profit: ₹42.34Cr as on June 2025 (Q1 FY26)
Listing date: 23 Dec, 2021
Chairperson Name: GANGADI MADHUKAR REDDY
| Organisation | Medplus Health Services Ltd |
| Industry | Retail |
| CEO | GANGADI MADHUKAR REDDY |
| E-voting on shares | Click here to vote |
Mutual Funds that own Medplus Stock
Check out the Mutual Funds with significant holdings in Medplus.
FAQs
What is Medplus share price today?
Medplus share price today stands at ₹813.8, Open: ₹806.9, Previous Close: ₹804.05, High: ₹829.6, Low: ₹805.35, 52 Week High: ₹1045.3, 52 Week Low: ₹616 as on .
How to buy Medplus shares ?
To buy Medplus shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for MEDPLUS or Medplus Health Services Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Medplus shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Medplus?
Today's traded volume of Medplus is 2.04L. Which means that 2.04L shares of Medplus were bought and sold on the stock market during today's trading session.
What is Medplus's market cap today?
Today's market capitalisation of Medplus is ₹9,744.72 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Medplus?
Medplus’s 52 week high is ₹1045.3 and 52 week low is ₹616. The current share price of Medplus is ₹813.8, which is -22.15% down from its 52 week high and 32.11% up from its 52 week low.